# AI in Molecular Dynamics and Protein–Ligand Binding Free-Energy Calculations

## Overview

AI is currently most useful as a **complement** to physics-based methods such as molecular dynamics (MD), umbrella sampling, metadynamics, FEP, TI, ABFE, and RBFE, rather than a universal replacement. In some narrower tasks—especially rapid screening, structure/pose prediction, and prioritization—AI can be much faster. Whether it outperforms a conventional method depends on the task, the benchmark, and how well the model generalizes to new proteins and ligands.

## 1. Where AI helps

### A. Predicting protein–ligand structures

Models such as **AlphaFold 3** and **Boltz-2** can generate candidate protein–ligand complex structures. This can help when an experimental complex structure is unavailable. A plausible pose, however, does **not** by itself establish a reliable binding free energy.

### B. Improving enhanced sampling

Machine learning can identify slow collective variables (CVs) from MD trajectories, potentially revealing motions missed by simple ligand–protein distances or individual dihedrals. Learned CVs may be combined with umbrella sampling, metadynamics, and related methods. Examples of approaches include time-lagged autoencoders and VAMP-based models.

### C. Improving interaction models

Machine-learned interatomic potentials can approximate quantum-mechanical potential-energy surfaces and may improve selected aspects of molecular interaction modeling. Their usefulness for binding free energies still depends on transferability, sampling, treatment of solvent, and validation.

### D. Prioritizing free-energy calculations

AI models can rank or filter large ligand libraries and use existing experimental or FEP results to recommend the next compounds to evaluate. This is often described as **active learning**.

## 2. AI versus conventional methods

| Task | Practical assessment |
|---|---|
| Rapid screening of thousands of ligands | AI often offers a major speed advantage. |
| Predicting candidate binding poses | AI can be competitive, but poses need validation. |
| Quantitative RBFE for related ligands | Carefully validated physics-based FEP remains a strong method. |
| Rigorous ABFE for a new ligand | AI is not a general replacement for a complete thermodynamic calculation. |
| Finding slow protein or ligand motions | AI-assisted CV discovery is promising. |
| Mechanistic interpretation | MD remains valuable for examining conformational transitions, hydration, and dynamics. |

**Important:** A model's performance on familiar benchmark compounds does not guarantee reliable predictions for new chemical series. Comparisons should consider prospective validation, uncertainty, and whether training data overlap with the test set.

## 3. Example hybrid AI + FEP workflow

Consider **1,000 candidate ligands** for one protein:

1. **AI screening / structure prediction:** rank compounds and propose plausible bound poses.
2. **Selection:** choose a manageable subset, such as 50 compounds (illustrative number).
3. **Preparation and MD:** validate structures, protonation states, force-field parameters, and stability of the binding poses.
4. **RBFE or ABFE:** compute quantitative binding free energies with appropriate sampling and uncertainty analysis.
5. **Experimental testing:** measure affinities for prioritized compounds.
6. **Active-learning update:** use the new experimental and/or simulation results to refine which compounds are selected next.

This approach uses AI to reduce the search space and physics-based methods to provide more defensible thermodynamic estimates.

## 4. How to incorporate AI into a NAMD workflow

### Before MD

- Generate or compare candidate protein–ligand poses with AI structure-prediction tools.
- Inspect pocket geometry, ligand stereochemistry, protonation, and key interactions.
- Prepare and equilibrate the system with a validated force field (for example, CHARMM36 for protein and CGenFF for ligand).

### During enhanced-sampling design

- Run exploratory NAMD simulations and save trajectories (for example, DCD files).
- Extract structural features: distances, contacts, dihedrals, solvent exposure, and pocket-opening coordinates.
- Train or apply a model that identifies slow coordinates, such as a time-lagged autoencoder or VAMP-based approach.
- Validate the learned CVs and use them in metadynamics or umbrella sampling when technically supported.

### During ligand prioritization

- Use AI to select promising or informative ligand transformations.
- Apply RBFE to chemically related ligands, or ABFE when an absolute affinity estimate is needed.
- Examine overlap, convergence, independent replicates, and statistical uncertainty.

## 5. Limitations and cautions

- **A predicted binding pose is not a binding free energy.**
- **Fast predictions are not automatically more accurate.** Performance is system- and benchmark-dependent.
- **ML-enhanced sampling still needs validation.** A learned CV can omit slow degrees of freedom.
- **Force-field and sampling errors remain.** AI does not automatically solve water rearrangement, protonation, ligand flexibility, or rare conformational transitions.
- **Binding thermodynamics and kinetics are different.** A good affinity prediction does not necessarily give a reliable dissociation rate or residence time.

## 6. Suggested reading

- [Enhanced Sampling in the Age of Machine Learning (Chemical Reviews, 2026)](https://pmc.ncbi.nlm.nih.gov/articles/PMC12810258/)
- [Integrating Machine Learning into Free Energy Perturbation Workflows (Journal of Chemical Information and Modeling, 2025)](https://pmc.ncbi.nlm.nih.gov/articles/PMC12529772/)

## Bottom line

For practical protein–ligand work, a strong strategy is **AI for pose generation, CV discovery, and prioritization; physics-based MD and alchemical free-energy methods for mechanistic and quantitative thermodynamic analysis; experiments for validation**.

For a NAMD user, an especially useful first AI project is to analyze exploratory DCD trajectories to learn slow collective variables, then compare AI-derived CVs with a conventional ligand-distance CV in an enhanced-sampling calculation.
